Institutional investors purchased a net $37.6 thousand shares of ROSG during the quarter ended December 2014 and now own 4.01% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HIGHLANDER CAPITAL MANAGEMENT LL... Bought 46.0 Thousand shares of Rosetta Genomics Ltd
INVESTORS CAPITAL CORP. Bought 20.8 Thousand shares of Rosetta Genomics Ltd
ROTELLA CAPITAL MANAGEMENT, INC. Bought 20.0 Thousand shares of Rosetta Genomics Ltd